• Протек
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 2
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 4
    LEADERSHIP
    THROUGH PARTNERSHIP

CV PROTEK Becomes a Distributor No. 1

At the end of 9 months of 2016 CV PROTEK became a leader again in the total cumulative rating of the largest pharmaceutical distributors, according to IMS Health analytical agency.
Now CV PROTEK occupies 18.4% of the market of pharmaceuticals direct sales. Its share has grown by 4.4% over the corresponding period of 2015.
“PROTEK has a long-term strategy which is centered around business processes efficiency and profit making. The top position in the rating is a result of such strategy progressive implementation”, commented Dmitry Pogrebinsky, the General Director of CV PROTEK, on the rating results.

ТОР10 major distributors by direct sales of pharmaceuticals (including preferential medication), Q1-3 2016 according to IMS Health
 

Rating Distributor Share in direct sales, %
Q1-3 2016 Q1-3 2015
1 Protek 18.4% 14.0%
2 Katren 18.0% 19.7%
3 Pulse 12.2% 10.5%
4 Rosta 9.8% 11.8%
5 SIA International* 7.2% 7.3%
6 R-PHARM** 5.4% 6.3%
7 BSS 4.3% 2.9%
8 Profitmed 2.2% 0.9%
9 Euroservice 1.5% 1.3%
10 Irvin 2** 0.9% 0.6%
Total 79.93% 75.35%


 *Expert’s estimate
**- most distribution activities are supplies of the budget sector (government programmes)

ZdravCity has become a partner of Mail.Ru Group as part of the new online service for searching and ordering medicines

You can take your order in the nearest pharmacy - pharmacies within the settlement will be shown on the map and... more...

CV PROTEK once again received the “Platinum Ounce”

CV PROTEK once again received the “Platinum Ounce”

Since the the first time the “Platinum Ounce” award ceremony was held, CV PROTEK was recognized as a winner amo... more...

Participants of “My Health” programme - holders of “My Health” plastic cards - will be able to use the 10-percent discount for testing in Citilab laboratories from March

The list of services the discount is granted for includes more than 1.8 thousand tests in the spheres of immuno... more...